Constrictive pericarditis of tuberculous etiology in the HIV-positive patient: Case report and review of the literature;Pericardite constritiva de etiologia tuberculosa no doente VIH-positivo: Caso clínico e revisão bibliográfica

Revista Portuguesa de Cardiologia

Volumn 25, Issue 11, 2006, Pages 1029-1039

  Sá, Isabel ^a   Môço, Rui ^a   Cabral, Sofia ^a   Reis, António Hipólito ^a   Pereira, Luís Sousa ^a   Torres, Severo ^a   Gomes, J Lopes ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Constrictive pericarditis; HIV; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; TUBERCULOSTATIC AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONSTRICTIVE PERICARDITIS; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; HEART FAILURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MALE; PERICARDIAL EFFUSION; PERICARDIECTOMY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VIRUS DETECTION;

ADULT; HIV SEROPOSITIVITY; HUMANS; MALE; PERICARDITIS, CONSTRICTIVE; PERICARDITIS, TUBERCULOUS;

EID: 33846310343     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Pozniak AL, Weinberg J, Mahari M, Neill P, Houston S, Latif A. Tuberculous pericardial effusion associated with HIV infection: a sign of disseminated disease. Tubercle and Lung Disease 1994;75:297-300.
2. Colvin M, Abdool SSK. HIV infection among patients with tuberculosis in ZwaZulu-Natal. South Africa [letter]. Int J Tuberc Lung Dis 1998;2:172.
3. Hakim JG, Ternouth I, Mushangi E, Siziya S, Robertson V, Malin A. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 2000;84:183-88.
4. LeWinter M, Kabhani S. Pericardial diseases. In: Zipes DP, Libby P, Bonow R, Braunwald E, editors. Braunwald's Heart Disease: textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier Saunders: 2005, p. 1757-1780.
5. Wragg A, Strang JIG. Tuberculous pericarditis and HIV infection. Heart 2000;84:127-128.
6. Williams IP, Hetzel MR. Tuberculous pericarditis in south-west London: an increasing problem. Thorax 1978;33:816-17.
7. Trautner BW, Darouiche RO. Tuberculous Pericarditis: optimal diagnosis and management. Clin Infect Dis 2001;33:954-61.
8. Senag. De la structure, del'action et dês maladies du coeur. 1749.
9. Harvey AM, Whitehill MR. Tuberculous pericarditis. Medicine (Baltimore) 1937;16:45-94.
10. Ortbals DW. Tuberculous Pericarditis. Arch Intern Med 1979;139:231-4.
11. Pugliese A, Isnardi D, Saini A, et al. Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 2000;40:282-84.
12. Cegielski GJ, Ramiya K, Lallinger GJ, Mtulia IA, Mbaga IM. Pericardial disease and human immunodeficiency vírus in Dar es Salaam, Tanzânia. Lancet 1990;335:209-12.
13. Cegielski JP, Lwakatare J, Dukes CS, Lema LE, Lallinger GJ, Kitinya J, et al. Tuberculous pericarditis in Tanzania patients with HIV infection. Tuber Lung Dis 1994;775:429-34.
14. Barbaro G, Klatt EC. HIV infection and the cardiovascular system. AIDS Rev 2002;4:93-103.
15. Perronne C, Ghoubontni A, Leport C, Salman-Céron D, Bricaire F, Vildé JL. Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV? Tubercle Lung Dis 1992;73:39-44.
16. Estok L, Wallach F. Cardiac tamponade in a patient with AIDS: a review of pericardial disease in patients with HIV infection. Mt Sinai J Med 1998;65:33-39.
17. Cherian G, Habashy AG, Uthaman B, et al. Detection and follow-up of mediastinal lymph node enlargement in tuberculous effusions using computed tomography. Am J Med 2003;114:319-22.
18. Cherian G. Diagnosis of tuberculous aetiology in pericardial effusions. Postgrad Med J 2004;80:262-6.
19. Klein JS. The hila. In: Brant WE, Helms CA, eds. Fundamentals of diagnostic radiology. Baltimore: Williams and Wilkins, 1994:390-411.
20. Stanford W. Computed tomography and ultrafast computed tomography in pericardial disease. In: Elliott LP, editor. Cardiac Imaging in infants, children and adults. Philadelphia, USA: JB Lippincott;1991:415-20.
21. Burgess LJ, Reuter H, Carstens ME, Taljaard J, Doubell AF. The Use of Adenosine deaminase and Interferon-γ as Diagnostic Tools for Tuberculous Pericarditis. Chest 2002;122:900-905.
22. Cegielski JP, Devlin BH, Morris AJ, et al. Comparison of PCR, culture, and histopathology for diagnosis of tuberculous pericarditis. J Clin Microbial 1997;35:3254-7.
23. Strang JIG, Kakaza HHS, Gibson DG, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone treatment of tuberculous pericardial effusion in the Transkei. Lancet 1988;ii:759-64.
24. Rooney JJ, Crocco JA, Lyons HA. Tuberculous pericarditis. Ann Intern Med 1970;72:73-8.
25. Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, Astemborski J, Vlahov D. Prevalence of tuberculin positivity and skin test anergy in HIV-1 seropositive and - seronegative intravenous drug users. JAMA 1992;267(3):369-73.
26. Markowitz N, Hansen N, Wilcosky T, Hopewell P, Glassroth J, Kvale P, Mangura B, Osmond D, Wallace J, Rosen M, Reichman L. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Inter Med 1993;119(3):185-93.
27. Lin DS, Tipton RE. Ga-67 cardiac uptake. Clin Nucl Med 1983;8:603-4.
28. Schmidt U, Rebarber IF. Tuberculous pericarditis identified with gallium-67 and indium-111 leukocyte imaging. Clin Nucl Med 1994;19:146-7.
29. Sagrista-Sauleda J, permanyer-Miralda G, Soler-Soler J. Tuberculous pericarditis: ten year experience with a prospective protocol for diagnosis and treatment. J Am Coll cardiol 1988;2:724-8.
30. Desai HN. Tuberculous pericarditis. A review of 100 cases. S Afr Med J 1979;55:877-80.
31. Koh KK, Kim EJ, Cho CH, e tal. Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation 1994;89:2728-2735.
32. Long R, Younes M, Patton M, et al. Tuberculous pericarditis: long term outcome in patients who received medical therapy alone. Am Heart J 1989;117:1133-9.
33. Kawecka-Jazcz K. Pericarditis: classification, etiology, pathogenesis. Folia Med Cracov 1991;32:15-22.
34. Elliott AM, Halwiindi B. Bagshawe A, et al. Use of prednisolone in the treatment of HIV positive tuberculosis patients. QJ Med 1992;85:855-60.
35. Gill PS, Loureiro C, Beinstein-Singer M, et al. Clinical effects of glucocorticoids in kaposi's sarcoma related to the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989;110:937-40.
36. Soler-Soler J, Sagrista-Sauleda J, Permanyer-Miralda G. Management of pericardial effusion. Heart 2001;86:235-40.
37. Spodick DH. Pericardial Diseases. In: Braunwald E. Heart Disease - A Textbook of Cardiovascular Disease. WB Saunders Company 6th ed. 2001;50:1823-76.
38. Manning WJ. Pericardial disease. In: Goldman L, Bennet JC. Cecil Textbook of Medicine. WB Saunders Company 21st ed. 2000;65:347-53.
39. Harries AD. Tuberculosis and human immune-deficiency virus infection in developing countries. Lancet 1990;335:387-90.